| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_483c97b603b85d7d1ac4b05945c2772d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0100bcec9ae600328d87af96423717d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a13031d2b8d25af73266afdad4e06883 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
| filingDate |
2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cdabe1b76f5664ab4ed78077fb86cde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5aa578dffa65a94d76bd66c6dae7516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df91d1d9c5882b5d7a3d26c53f0bf761 |
| publicationDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120001977-A |
| titleOfInvention |
Composition for the prevention and treatment of brain diseases, including purified extract or fraction of camphor ginseng leaf as an active ingredient |
| abstract |
The present invention relates to a composition comprising purified extracts or fractions of leaves of Mountain Cultivated Ginseng Radix as an active ingredient, and more particularly, a composition comprising purified extracts or fractions of leaves of camphor ginseng as an active ingredient. (acetylcholinesterase) inhibits the activity, and scopolamine (scopolamine) induced a forgetfulness in the experimental animal model of the learning ability and cognitive function, so the composition is a pharmaceutical composition or health functional food for the prevention and treatment of brain diseases It can be usefully used. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3616704-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190123045-A |
| priorityDate |
2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |